Consolidated cash flow statement

in CHF 000s

 

2022

2021

Profit incl. minority interests

190,604

230,686

Net interest expense

14,072

6,399

Income taxes

38,941

45,202

Result from sale of fixed assets

-878

-2,958

Depreciation and amortisation

111,273

108,756

Impairment charges

15,110

1,903

Change in provisions

974

-7,559

Income from associates and joint ventures

148

-3,718

Other non-cash adjustments

6,914

-4,600

Cash flow before changes in net working capital, interest and taxes

377,158

374,111

 

 

 

Change in inventories

-76,150

-50,737

Change in trade receivables

-66,143

-19,281

Change in other receivables, prepayments and accrued income

-3,741

-12,828

Change in trade payables

39,194

14,855

Change in other payables, accrued liabilities and deferred income

-4,394

7,955

Interest paid

-15,705

-6,989

Taxes paid

-41,871

-47,180

Cash flow from operating activities

208,348

259,906

 

 

 

Investments in property, plant and equipment

-200,264

-151,196

Proceeds from disposal of property, plant and equipment

1,992

4,166

Investments in intangible assets

-4,307

-6,218

Acquisition of consolidated investments/businesses

-5,983

-261,823

Acquisition of minority interests

-17,558

-15,009

Change in loans receivable

-4,985

67

Dividend received

782

700

Interest received

2,155

654

Cash flow from investing activities

-228,168

-428,659

 

 

 

Change in other current financial liabilities

-65,838

-1,064

Change in other non-current financial liabilities

108,942

-2,833

Proceeds from bond-issuance

200,416

Share of minority shareholders in capital increases of Group companies

10,847

Dividend payments to shareholders

-74,897

-69,548

Dividend payments to minority shareholders

-2,148

-5,681

Cash flow from financing activities

-23,094

121,290

 

 

 

Currency translation

-2,172

73

Net change in cash and cash equivalents

-45,086

-47,390

 

 

 

Cash and cash equivalents at beginning of period

247,281

294,671

Cash and cash equivalents at end of period

202,195

247,281